Skip to the page

Data / Form D filings / JML BIOTECH INVESTORS, LLC

JML BIOTECH INVESTORS, LLC: Form D filing

JML BIOTECH INVESTORS, LLC, a biotechnology company in Houston, TX, filed a Form D with the SEC in 2026. The latest, on February 13, 2026, reports an offering of $5 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11923 LONGLEAF LANE, Houston, TX, 77024
Phone
(832) 654-6007
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b), Investment Company Act section 3(c), section 3(c)(1)
SEC identifier (CIK)
2100894

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 13, 2026New notice$5,000,000$0$5,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
* JML BIOTECH MANAGEMENT, LLCExecutive Officer, PromoterMANAGER OF ISSUER

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Feb 9, 2026 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what JML BIOTECH INVESTORS, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.